Salvat   Report issue

For profit Phase 2 Phase 3
Founded: Barcelona Spain (1898)

Organization Overview

First Clinical Trial
2006
NCT00507169
First Marketed Drug
2016
ciprofloxacin (cipro)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Laboratorios Salvat | LABORATORIOS SALVAT | Salvat